Bioventus Inc.

IPO

Bioventus Inc. is a biotech company in Durham, United States, founded in 2012.

Innovations For Active Healing

Employees
1001–5000
Founded
2012
Business Model
B2B
Type
Public

Indexed holds 2 investors for this company. The full record is or through the API.

About

Bioventus is a global leader of innovations for active healing and surgical orthobiologics, delivering a comprehensive portfolio of clinically efficacious and cost-effective solutions for patients, physicians, and payers. Established in 2012 and headquartered in Durham, North Carolina, the company trades publicly on Nasdaq under the ticker BVS and employs more than 1,200 people worldwide, with product lines spanning pain treatments, restorative therapies, and surgical solutions.

Summary

It lists 1001–5000 employees. Investors include Essex Woodlands Health Ventures and Smith & Nephew.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Exit History

Data from Indexed.vcUpdated
IPOFeb 2021
$104.0M

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Acquisitions

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Bioventus Inc. on Indexed.vc
<a href="https://indexed.vc/companies/bioventus-inc"><img src="https://indexed.vc/api/badge/company/bioventus-inc" alt="Bioventus Inc. on Indexed.vc" width="260" height="76" /></a>